Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis.

about

Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis.

Item

http://www.wikidata.org/entity/Q54994475

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Upregulated long non-coding RN ...... er detection: a meta-analysis.

@en

Upregulated long non-coding RN ...... er detection: a meta-analysis.

@nl

type

Item

label

Upregulated long non-coding RN ...... er detection: a meta-analysis.

@en

Upregulated long non-coding RN ...... er detection: a meta-analysis.

@nl

prefLabel

Upregulated long non-coding RN ...... er detection: a meta-analysis.

@en

Upregulated long non-coding RN ...... er detection: a meta-analysis.

@nl

P1476

Upregulated long non-coding RN ...... er detection: a meta-analysis.

@en

P2093

Guozheng Yu

http://www.w3.org/2001/XMLSchema#string

Lin Xia

http://www.w3.org/2001/XMLSchema#string

Linyan Zhu

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

Global cancer statistics, 2012

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Assessing the probability that a positive report is false: an approach for molecular epidemiology studies

Long non-coding RNAs and enhancers.

Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival.

Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening: A pooled analysis of individual studies.

Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers

Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.

P304

1491-1499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S152241

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29588602

http://www.w3.org/2001/XMLSchema#string

P932

5860138

http://www.w3.org/2001/XMLSchema#string